EcoDrugPlus

Caspase 8

Ensembl ID : ENSMOCG00000001017
Gene Symbol: CASP8
3 Cross references
132 Possible Orthologues:

Caspase 9

Ensembl ID : ENSMOCG00000020323
Gene Symbol: CASP9
3 Cross references
202 Possible Orthologues:

Catechol-O-Methyltransferase

Ensembl ID : ENSMOCG00000012717
Gene Symbol: COMT
3 Cross references
275 Possible Orthologues:

Cathepsin C

Ensembl ID : ENSMOCG00000014577
Gene Symbol: CTSC
3 Cross references
233 Possible Orthologues:

Cathepsin K

Ensembl ID : ENSMOCG00000022513
Gene Symbol: CTSK
3 Cross references
240 Possible Orthologues:

Cathepsin S

Ensembl ID : ENSMOCG00000022241
Gene Symbol: CTSS
3 Cross references
269 Possible Orthologues:

Cell Division Cycle 7

Ensembl ID : ENSMOCG00000010463
Gene Symbol: CDC7
3 Cross references
208 Possible Orthologues:

Checkpoint Kinase 1

Ensembl ID : ENSMOCG00000003709
Gene Symbol: CHEK1
3 Cross references
177 Possible Orthologues:

Checkpoint Kinase 2

Ensembl ID : ENSMOCG00000009496
Gene Symbol: CHEK2
2 Cross references
203 Possible Orthologues:

Chemokine (C-X-C Motif) Receptor 4

Ensembl ID : ENSMOCG00000002883
Gene Symbol: CXCR4
1 Cross references
283 Possible Orthologues:

Cholecystokinin A Receptor

Ensembl ID : ENSMOCG00000004693
Gene Symbol: CCKAR
3 Cross references
200 Possible Orthologues:

Cholecystokinin B Receptor

Ensembl ID : ENSMOCG00000016332
Gene Symbol: CCKBR
3 Cross references
264 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).